Prevention, diagnosis and treatment of venous thromboembolism
DOI:
https://doi.org/10.12775/JEHS.2020.10.06.009Keywords
venous thromboembolism, pulmonary embolism, deep vein thrombosisAbstract
The formation of a thrombus in a vein leads to a narrowing of its lumen and a reduction in blood flow, which results in the development of venous thromboembolism (VTE). It manifests itself in most cases, including pain, swelling and redness of the affected limb. Data published in 2007 indicate that in 6 European Union countries as many as 370,000 deaths per year are a consequence of deep vein thrombosis (DVT), which is 75% a consequence of hospitalization. [2] [11] The causes of blood clots are found in the factors of the so-called Virchow triad. The main risk factors for venous thromboembolism as well as its complications of pulmonary embolism include thrombophilia, advanced age, previous VTE, immobilization of trauma or surgery. In the diagnosis of VTE, the determination of D-dimer level plays a key role.References
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998). Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Archives of internal medicine, 158(6), 585-593.
Wojtasińska, E. Wrodzona trombofilia jako czynnik ryzyka żylnej choroby zakrzepowo-zatorowej.
Khan, S., & Dickerman, J. D. (2006). Hereditary thrombophilia. Thrombosis Journal, 4(1), 15.
Chmielewski, D., Górecki, A., Kusz, D., Małdyk, P., Marczyński, W., & Tomkowski, W. (2009). Zasady profilaktyki żylnej choroby zakrzepowo-zatorowej w ortopedii i traumatologii narządu ruchu. Ortopedia Traumatologia Rehabilitacja. Medsportpress, 1(6), 86-92.
Wells, P. S., Anderson, D. R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., ... & Lewandowski, B. (1997). Value of assessment of pretest probability of deep-vein thrombosis in clinical management. The Lancet, 350(9094), 1795-1798.
Wells, P., Hirsh, J., Anderson, D., Lensing, A. A., Foster, G., Kearon, C., ... & Girolami, A. (1995). Accuracy of clinical assessment of deep-vein thrombosis. The Lancet, 345(8961), 1326-1330.
Windyga, J., Podolak-Dawidziak, M., & Chojnowski, K. (2010). Zasady rozpoznawania żylnej choroby zakrzepowo-zatorowej. Hematologia, 1(2), 93-101.
Wells, P. S., Anderson, D. R., Rodger, M., Ginsberg, J. S., Kearon, C., Gent, M., ... & Bowie, D. (2000). Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thrombosis and haemostasis, 83(03), 416-420.
Kearon, C., & Hirsh, J. (2001). Prevention of venous thromboembolism. Hemostasis and thrombosis. Philadelphia Pa: Lippincott, Williams and Wilkins, 1405-12.
Gutknecht, P., Łuszczyńska-Nitka, G., & Siebert, J. (2007). Żylna choroba zakrzepowo-zatorowa w praktyce lekarza rodzinnego. In Forum Medycyny Rodzinnej (Vol. 1, No. 2, pp. 115-124).
Cohen, A. T., Agnelli, G., Anderson, F. A., Arcelus, J. I., Bergqvist, D., Brecht, J. G., ... & Mottier, D. (2007). Venous thromboembolism (VTE) in Europe. Thrombosis and haemostasis, 98(10), 756-764.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 289
Number of citations: 0
